[1]
F. Bardazzi, “Psoriasis With Leg Involvement, a New Difficult-to-Treat Area: A Cohort Study of Patients Treated With Risankizumab”, Dermatol Pract Concept, vol. 14, no. 3, p. e2024171, Jul. 2024, doi: 10.5826/dpc.1403a171.